Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modulators of the kynurenine pathway of tryptophan metabolism: synthesis and preliminary biological evaluation of (S)-4-(ethylsulfonyl)benzoylalanine, a potent and selective kynurenine aminotransferase II (KAT II) inhibitor.

× No keyword cloud information.

31 in total

1. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.

Authors: Michelle C Potter; Greg I Elmer; Richard Bergeron; Edson X Albuquerque; Paolo Guidetti; Hui-Qiu Wu; Robert Schwarcz
Journal: Neuropsychopharmacology Date: 2010-03-24 Impact factor: 7.853

2. Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?

Authors: Robert Schwarcz; Christopher A Hunter
Journal: Schizophr Bull Date: 2007-04-13 Impact factor: 9.306

3. Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse.

Authors: Manuela Schmid; Maik J Lehmann; Richard Lucius; Nishith Gupta
Journal: J Biol Chem Date: 2012-04-25 Impact factor: 5.157

Review 4. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.

Authors: Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal: Cell Mol Life Sci Date: 2009-10-15 Impact factor: 9.261

5. Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Authors: Hui-Qiu Wu; Masahiro Okuyama; Yasushi Kajii; Ana Pocivavsek; John P Bruno; Robert Schwarcz
Journal: Schizophr Bull Date: 2014-03 Impact factor: 9.306

Review 6. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

Authors: Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Jun Ku Chung; Philip Gerretsen; Julia Kim; Hiroyoshi Takeuchi; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal: Schizophr Bull Date: 2017-07-01 Impact factor: 9.306

7. Crystal structure-based selective targeting of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement.

Authors: Franca Rossi; Casazza Valentina; Silvia Garavaglia; Korrapati V Sathyasaikumar; Robert Schwarcz; Shin-Ichi Kojima; Keisuke Okuwaki; Shin-Ichiro Ono; Yasushi Kajii; Menico Rizzi
Journal: J Med Chem Date: 2010-08-12 Impact factor: 7.446

Review 8. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors: Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal: CNS Drugs Date: 2009 Impact factor: 5.749

9. Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNγ-regulated host pathways for the parasite development.

Authors: Manuela Schmid; Emanuel Heitlinger; Simone Spork; Hans-Joachim Mollenkopf; Richard Lucius; Nishith Gupta
Journal: Mucosal Immunol Date: 2013-12-25 Impact factor: 7.313

10. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.

Authors: Hui-Qiu Wu; Edna F R Pereira; John P Bruno; Roberto Pellicciari; Edson X Albuquerque; Robert Schwarcz
Journal: J Mol Neurosci Date: 2009-08-19 Impact factor: 3.444